Till Finansinspektionens startsida

Börsinformation

IssuerBioInvent International Aktiebolag


Holder
Ridgeback Capital Management LP

Instrument
InstrumentCommon shares SE0000789711
Before the transaction
SharesData not given*
Voting rightsData not given*
Transaction
Reason for major shareholding notificationSell
Date19/03/2013
Limit for number of shares5 %
Limit for number of votes5 %
After the transaction
Quantity
Shares3,627,456
Directly held voting rights3,627,456
Indirectly held voting rights0
Percentage
Directly held shares4.9 %
Directly held voting rights4.9 %
Indirectly held voting rights0 %
 
Resulting distribution of total holdings
Percentage of voting rights: Number of underlying shares:
Shares  
Instruments - FITA Ch. 4, section 2, first paragraph, line 2  
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
 -  Physically settled  
 -  Cash settled  
   
Total  
 

Chain of controlling companies
Voting rights% Voting rightsCompany
3,627,4564.9Ridgeback Capital Inv. LP
Group total holdings
Voting rights3,627,456
Percentage of voting rights4.9

Published
30/07/2013 09:22
Contact
NameBud Holman
Phone**** Email**** 
*)Note that neither phone nor email is published on fi.se

The legal basis for FI to compile and publish these so-called major shareholding notification announcements is that this document is necessary for FI to carry out a task in the public interest (Article 6(1)(e) of the General Data Protection Regulation). Chapter 4 of Act (1991:980) sets forth that major shareholders are obligated under certain conditions to notify FI when buying or selling shares and that FI must disclose this information. Chapter 12, sections 10–11 of FFFS 2007:17 specifies the required content of the major shareholding notification. Read more about FI’s processing of personal data here www.fi.se/sv/om-fi/dataskydd-och-behandling-av-personuppgifter-pa-fi/

*Source of information has chosen not to submit the data
 
Tfn 08-408 980 37
Fax 08-24 39 25